Cruz LJ - Search Results

1

Design of a minimized cyclic tetrapeptide that neutralizes bacterial endotoxins.

Mora P, Mas-Moruno C, Tamborero S, Cruz LJ, Pérez-Payá E, Albericio F. Mora P, et al. Among authors: cruz lj. J Pept Sci. 2006 Jul;12(7):491-6. doi: 10.1002/psc.755. J Pept Sci. 2006. PMID: 16625684

2

Tiratricol neutralizes bacterial endotoxins and reduces lipopolysaccharide-induced TNF-alpha production in the cell.

Cascales L, Mas-Moruno C, Tamborero S, Aceña JL, Sanz-Cervera JF, Fustero S, Cruz LJ, Mora P, Albericio F, Pérez-Payá E. Cascales L, et al. Among authors: cruz lj. Chem Biol Drug Des. 2008 Oct;72(4):320-8. doi: 10.1111/j.1747-0285.2008.00703.x. Chem Biol Drug Des. 2008. PMID: 18844678

3

Nanostructure formation enhances the activity of LPS-neutralizing peptides.

Mas-Moruno C, Cascales L, Cruz LJ, Mora P, Pérez-Payá E, Albericio F. Mas-Moruno C, et al. Among authors: cruz lj. ChemMedChem. 2008 Nov;3(11):1748-55. doi: 10.1002/cmdc.200800209. ChemMedChem. 2008. PMID: 18833552

4

Design and facile solid-phase synthesis of peptide-based LPS-inhibitors containing PEG-like functionalities.

Mas-Moruno C, Cascales L, Mora P, Cruz LJ, Pérez-Payá E, Albericio F. Mas-Moruno C, et al. Among authors: cruz lj. Biopolymers. 2009;92(6):508-17. doi: 10.1002/bip.21285. Biopolymers. 2009. PMID: 19637366

5

Smallest peptoids with antiproliferative activity on human neoplastic cells.

Mas-Moruno C, Cruz LJ, Mora P, Francesch A, Messeguer A, Pérez-Paya E, Albericio F. Mas-Moruno C, et al. Among authors: cruz lj. J Med Chem. 2007 May 17;50(10):2443-9. doi: 10.1021/jm061166z. Epub 2007 Apr 14. J Med Chem. 2007. PMID: 17432841

6

Design and synthesis of FAJANU: a de novo C(2) symmetric cyclopeptide family.

Garcia-Martin F, Cruz LJ, Rodriguez-Mias RA, Giralt E, Albericio F. Garcia-Martin F, et al. Among authors: cruz lj. J Med Chem. 2008 Jun 12;51(11):3194-202. doi: 10.1021/jm800047b. Epub 2008 May 8. J Med Chem. 2008. PMID: 18461923

7

The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targets.

Luque-Ortega JR, Cruz LJ, Albericio F, Rivas L. Luque-Ortega JR, et al. Among authors: cruz lj. Mol Pharm. 2010 Oct 4;7(5):1608-17. doi: 10.1021/mp100035f. Epub 2010 Aug 17. Mol Pharm. 2010. PMID: 20715776

8

Synthesis and structure-activity relationship of cytotoxic marine cyclodepsipeptide IB-01212 analogues.

Cruz LJ, Francesch A, Cuevas C, Albericio F. Cruz LJ, et al. ChemMedChem. 2007 Jul;2(7):1076-84. doi: 10.1002/cmdc.200700025. ChemMedChem. 2007. PMID: 17514692

9

Total solid-phase synthesis of marine cyclodepsipeptide IB-01212.

Cruz LJ, Cuevas C, Cañedo LM, Giralt E, Albericio F. Cruz LJ, et al. J Org Chem. 2006 Apr 28;71(9):3339-44. doi: 10.1021/jo051601h. J Org Chem. 2006. PMID: 16626112

10

Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents.

Cruz LJ, Luque-Ortega JR, Rivas L, Albericio F. Cruz LJ, et al. Mol Pharm. 2009 May-Jun;6(3):813-24. doi: 10.1021/mp8001039. Mol Pharm. 2009. PMID: 19317431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters